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In contrast to the dominant drug paradigm in which compounds were developed to “ﬁt all,”
new models focused around personalized medicine are appearing in which treatments are
developed and customized for individual patients. The agricultural biotechnology industry
(Ag-biotech) should also think about these new personalized models. For example, most
common herbicides are generic in action, which led to the development of genetically
modiﬁed crops to add speciﬁcity. The ease and accessibility of modern genomic analysis,
when wedded to accessible large chemical space, should facilitate the discovery of
chemicals that are more selective in their utility. Is it possible to develop species-selective
herbicides and growth regulators? More generally put, is plant research at a stage
where chemicals can be developed that streamline plant development and growth to
various environments?We believe the advent of chemical genomics now opens up these
and other opportunities to “personalize” agriculture. Furthermore, chemical genomics
does not necessarily require genetically tractable plant models, which in principle should
allow quick translation to practical applications. For this to happen, however, will require
collaboration between the Ag-biotech industry and academic labs for early stage research
and development, a situation that has proven very fruitful for Big Pharma.
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INTRODUCTION
Historically, the pharmaceutical industry has developed drug
treatments that target the widest segment of the population.
Although this business model has been very successful, there is
a need to update this “one size ﬁts all” approach to drug develop-
ment. Genetic variability in the human population renders some
individuals less responsive to certain therapies (McDonald et al.,
2009).More importantly, an individuals’geneticmakeup canmake
them susceptible to dangerous side effects from the medication
(Daly et al., 2009). This has led to suggestions that drug treat-
ments need to take into account a patients’ genome, hence the
development of the ﬁeld of pharmacogenomics (Weinshilboum
and Wang, 2006; Wang et al., 2011). By tailoring drugs regimens
to the needs of the individual based on their unique set of alleles,
more effective and safer therapies can be prescribed (Ginsburg and
Willard, 2009).
Understanding the molecular basis of disease is fundamental
to designing selective drug treatments. For example, over 1500
different mutations in the cystic ﬁbrosis transmembrane con-
ductance regulator (CFTR) gene have been identiﬁed in cystic
ﬁbrosis (CF) patients1. Although 90% of CF patients have an in-
frame deletion that results in themislocalization of the CFTR gene
product, a small fraction of CF patients (∼5%) have a missense
mutation G551D-CFTR that has correct CFTR localization but
reduced chloride channel activity (Van Goor et al., 2011). Using
this allelic information, researchers identiﬁed compounds that
1http://www.genet.sickkids.on.ca/cftr
speciﬁcally rectify the perturbation caused by each CFTR allele
(Ramsey et al., 2011; Van Goor et al., 2011). For example, the
drug Ivacaftor binds the ion channel to promote chloride trans-
port in patients harboring the G551D-CFTR allele (Yu et al., 2012;
McPhail and Clancy, 2013). Ivacaftor has been developed into
a clinically effective therapeutic under the trade name Kalydeco
(Whiting et al., 2014). During the development of novel CF thera-
peutics, genetics informed the drug discovery process and enabled
high-throughput screening to identify compounds that selectively
targeted each allele.
The parallels between the pharmaceutical and agricultural
chemical industry are striking. As with many pharmaceuticals,
the foundation of the Ag-chemical industry is the identiﬁcation
of chemicals that have generalized beneﬁts to a wide variety of
crops. Popular herbicides kill plants by targeting vital processes
conserved across plant biology but not found in mammals, such
as photosynthesis or amino acid biosynthesis (Table 1; Shaner,
2004), however, a broad-spectrum herbicide that targets a com-
mon process in plants may not prove beneﬁcial to a farmer
that is trying to selectively kill one type of plant while pre-
serving another. To overcome this issue, inventive Ag-biotech
companies deal with the indiscriminate action of these com-
pounds by engineering transgenic crops (GMOs) for herbicide
resistance (Mazur and Falco, 1989; Funke et al., 2006; Pollegioni
et al., 2011). This approach worked famously well for Monsanto
in the development of Roundup Ready crops that have been engi-
neered for resistance to glyphosate, the active ingredient in the
herbicide Roundup (Padgette et al., 1995). Glyphosate binds and
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Table 1 | Herbicide mode-of-action and chemical targets.
Mode of action Site of action Chemical family Resistant weed
species (U.S.)
Lipid synthesis Acetyl CoA carboxylase (ACCase) Arloxyphenoxy propionate
Cyclohexanedion
15
Amino acid synthesis Acetolactate synthease (ALS)
5-enolpyruvyl-shikimate-3-phosphate
synthase (EPSP)
Sulfonylurea
Glycine
38
7
Growth regulators Auxin receptor
Auxin transport
Phenoxy-carboxylic acid
Benzoic acid Semicarbazone
7
Photosynthesis Photosystem II electron transport Triazine, trazinone,
Nitrile,
Benzothiadiazole,
Ureas
22
1
7
Photosystem 1 electron transport Bipyridilium
Nitrogen metabolism Glutamine synthase Phosphonic acid 0
Pigment inhibitors Diterpene synthase
Hydroxyphenylpyruvate
dioxygenase
Isoxazolidinone
Isoxazole, triketone
0
0
Cell membrane disruptor PPO inhibitors Diethylether,
N -phenylphthalimide,
Thiadiazole
2
4
Seedling root growth Microtubule inhibitors Dinitroaniline 6
Seedling shoot growth Lipid synthesis
(non-ACCase)
Thiocarbamate 5
Long chain fatty acid inhibit Chloroacetamide 1
Broad-spectrum herbicides target a wide range of plant-speciﬁc processes, including photosynthesis and amino acid biosynthesis. The widespread use of herbicides
has selected for resistance in some common weed species, necessitating the development of novel pest control measures.
inhibits the 5-enolpyruvylshikimate-3-phosphate (EPSP) synthase
enzyme, the penultimate step in the shikimate biosynthesis (Pad-
gette et al., 1995; Funke et al., 2006). Roundup Ready plants express
a microbial EPSP synthase that does not bind glyphosate, and
are therefore resistant to the inhibitory effect of the herbicide
(Padgette et al., 1995; Funke et al., 2006). In this way, spraying
herbicides over engineered crops enables farmers to inhibit all
plant growth aside from the desired resistant plants (Padgette et al.,
1995).
DECONSTRUCTING THE HERBICIDE-GMO INDUSTRIAL COMPLEX
In the 1960s then U.S. President Dwight Eisenhower warned of
the developingmilitary-industrial complex that had formedwhich
resulted in the arms industry inﬂuencing military decisions and
vice versa. Facetiously, this argument could be applied to a mod-
ern view of herbicides and GMO technologies. In some sense,
industry wants the user to buy the herbicide resistant crop so that
they buy the company’s favorite herbicide. In other words the two
technologies are inextricably linked. Though the application of
broad-spectrum herbicides in combination with engineered resis-
tant crops has proven commercially successful, this model has led
to a lack of innovation (Dayan et al., 2012). A herbicide with a new
target site has not been commercialized in nearly 20 years (Dayan
et al., 2012). Lack of innovation has resulted in anAg-chem indus-
try now facing serious challenges, ranging from herbicide-tolerant
weed species to the environmental and ecological impacts of her-
bicide overuse (Benbrook, 2012). The issue of herbicide-resistant
weed species has become especially contentious of late, with the
emergence of the glyphosate-resistant weed Palmer amaranth now
prevalent in 23 states (Gilbert, 2013). From a non-science perspec-
tive, public opinion varies widely on the use of GMO-derived food
products (Hug, 2008; Bawa and Anilakumar, 2013; Kamle and Ali,
2013), putting further pressure on theAg-biotech industry. To con-
tinue to thrive, the Ag-chem industry should develop innovative
new products that circumvent the need for genetic engineering,
and are speciﬁc to the unmet needs of modern agriculture.
Innovative chemical solutions for crop protection may be
informed from studies that predate the GMO era. Most major
crop plants are monocots that contend with dicotyledonous weed
species, necessitating herbicides that selectively inhibit dicots. This
led to the development of broad leaf herbicides that exploit dif-
ferences between monocot and dicot seedling development. For
example, the broad leaf herbicide mesotrione, which inhibits the
enzyme 4-hydroxyphenylpyruvate dioxygenase (HPPD), is slowly
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transported and quickly metabolized by maize (Mitchell et al.,
2001). Given that monocots and dicots diverged 140–150 mil-
lion years ago (Chaw et al., 2004), it is perhaps not surprising that
differences in their metabolism can result in a herbicide that is
more effective in one class of plants versus another. This diver-
gence does raise questions, however, of whether compounds can
be identiﬁed that exploit interspecies variation on a smaller scale
for agronomic beneﬁt. A ﬁrst step to addressing these questions
is a better understanding of the pharmacogenetic variation across
the plant kingdom.
The accessibility of modern genomics now affords unparal-
leled opportunity to query genetic variation across plant species.
Genome sequences can be mined to identify species-speciﬁc path-
ways that could form the basis of targeted herbicide treatments.
Exploiting interspeciﬁc variation that has evolved in essential path-
ways can enhance herbicide speciﬁcity (Walker et al., 1988; Brown,
1990). For example, Auxinic herbicides are thought to mainly
target the auxin hormone receptor (Grossmann, 2010). These
compounds show species speciﬁc potencies based on differences
in uptake and metabolism (Sterling and Hall, 1997). Intriguingly,
mutants in Arabidopsis have been identiﬁed that are resistant to
the picolinate auxin picloram but not 2,4-D (Figure 1; Walsh
et al., 2006). One mechanism for this genotype-speciﬁc resistance
appears to be mutations in one of the ﬁve Arabidopsis TIR1 auxin
receptors (Walsh et al., 2006). Interestingly, a selective resistance to
piclorambut not to 2,4-D has been documented in the ﬁeld (Fuerst
et al., 1996; Sabba et al., 2003). In principal, these types of studies
demonstrate that natural variation in conserved essential path-
ways could be exploited to develop compounds that inhibit a weed
species yet are ineffective in a favored crop. Pharmacogenetic-
based bioinformatics could ﬁrst identify target alleles in weeds
and crops that could form the basis of chemical screens for com-
pounds that exhibit speciﬁcity toward the weed protein versus the
crop version.
TURNING OVER A NEW LEAF: PROMOTING PRODUCTIVITY, RATHER
THAN DEATH
Aside from its role in herbicide discovery, the Ag-biotech industry
also has a long history in the development of growth regulators
that enhance useful plant attributes (Figure 1). From the perspec-
tive of plant breeding, genetic manipulation of growth regulators
has been central to both horticulture and agriculture. Perhaps the
best example involves the impressive yield increases of the green
revolution of the 1960s (Davies, 2003), driven by breeding semi-
dwarfed varieties for decreased gibberellic acid (GA) biosynthesis
in rice and GA signaling in wheat (Hedden, 2003). In parallel to
breeding approaches, chemical inhibition of kaurene metabolism,
the metabolic precursor to GA, has been used to promote bene-
ﬁcial plant traits in crops (Rademacher, 1991; Gianfagna, 1995).
Compounds such as AMO1618 and phosphon D, which inhibit
kaurene synthesis, or ancymadol and triazole analogs that inhibit
kaurene oxidation, prevent lodging in cereals, increase fruit set in
grapes, control size in fruit trees and excessive vegetative growth
in cotton (Figure 1; Gianfagna, 1995). As an alternative to genetic
manipulation and dependence on elite crop varieties, chemical
treatments allow farmers the ﬂexibility to adjust crops in response
to changing environmental conditions.
These and many other examples of chemical applications for
horticultural or agronomic crop improvement were discovered
anecdotally by testing known growth regulators on various plant
species (Table A1 in Appendix; Gianfagna, 1995). The chemical
genomics era should now allow for a more systematic analy-
sis in this approach. For example, the plant hormone abscisic
acid (ABA) has important roles in protecting plants from abi-
otic stresses such as drought and cold (Ben-Ari, 2012). Rational
approaches to this problem have involved attempts to make sta-
ble ABA analogs, but have met with limited success (Zaharia
et al., 2005). Recently, a chemical screen identiﬁed a synthetic
naphthalene sulfonamide ABA agonist, Pyrabactin, which pref-
erentially binds an ABA receptor (Park et al., 2009). Although
Pyrabactin is mostly active during the germination stage (Park
et al., 2009), focused chemical screens built around a sulfonamide
substructure identiﬁed Quinabactin, which localizes ABA effects
to vegetative tissues and results in improved drought tolerance
(Okamoto et al., 2013). Thus, stable synthetic compounds that
modulates ABA synthesis or signaling may improve the plants
response to abiotic stress and promote productivity. It is easy
to envision a future in which a farmer that is experiencing
drought will apply Quinabactin-like compounds as a treatment
to avoid crop losses. By systematically screening for compounds
that mimic the activity of a plant hormone, researchers were
able to identify chemicals that act through a canonical hormone-
signaling pathway. As Pyrabactin bares no structural resemblance
to ABA, it is unlikely that modifying the natural ligand to the
receptor would have led to the discovery of a compound such
as Pyrabactin. This highlights the beneﬁt of screening chemi-
cal libraries to identify compounds that can be used as scaffolds
in the development of novel agonists or inhibitors of hormone
perception.
BACK TO THE FUTURE
Plant hormones such as auxin, GA, and ABA continue to be excel-
lent targets for theAg-chemical industry, and have a long-standing
history of being manipulated in plant biotechnology (Gianfagna,
1995). Given the successes of these biotechnological advances,
other hormones that regulate agriculturally important traits could
form the basis of future discovery. Functional analogs of the hor-
mone salicylic acid (SA), such as benzothiadiazole (BTH),promote
plant resistance to pathogens and have been developed for use in
the ﬁeld (Gorlach et al., 1996; Lawton et al., 1996). The success of
these analogs demonstrated the utility of targeting the SA pathway
in the development of compounds that promote cropproductivity.
This idea formed the basis of high-throughput chemical screens
that target SA signaling. Screening through compounds using cell
suspension cultures treated to pathogenic Pseudomonas identi-
ﬁed compounds that promote pathogen resistance in Arabidopsis
by invoking the hypersensitive cell death pathway in response to
pathogen attack (Noutoshi et al., 2012b). The inhibition of SA glu-
cosyltransferases promoted pathogen resistance by increasing SA
accumulation (Noutoshi et al., 2012b), whereas a set of functional
analogs induced SA signaling in planta (Noutoshi et al., 2012a).
Whether either of these approaches to plant defense signaling
will translate to ﬁeld applicability remains to be seen, however,
this approach has led to viable leads in the development of new
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FIGURE 1 | Structural diversity of compounds that modify plant hormone
signaling. Compounds that modulate hormone signaling have been identiﬁed
for major plant hormones. By targeting perception or metabolism, these
compounds can induce or inhibit hormone activity. High-throughput screening
can identify compounds that act on the hormone receptor yet bare no
structural resemblance to the natural ligand (for example, compare Pyrabactin
with ABA). These compounds can be used as scaffolds in the development of
novel agonists or antagonists of plant hormone perception.
agricultural treatments. At the very least, these chemicals can be
used to probe SA signaling pathways in plants (Noutoshi et al.,
2012a).
Though hormones present an obvious point to manipulate
plant output through chemical biology, metabolites can also serve
as signaling molecules that impact plant growth and development
(Kim et al., 1999; Stevenson et al., 2000; Hirai et al., 2003; Stokes
et al., 2013). By deﬁnition, proteins involved in metabolism bind
small molecules, and should therefore be druggable (Hopkins and
Groom, 2002). This should enable the development of chemicals
that antagonizemetabolic signaling pathways by acting as compet-
itive inhibitors. Over 1/3 of the Arabidopsis genome appears to be
involved in metabolism, and close to 200,000 enzymes have been
annotated across 17 species for which information is available2.
The plant metabolome may represent an area of untapped poten-
tial throughwhich chemical biology can facilitate the development
of novel plant growth regulators.
Once a metabolite has been discovered to inﬂuence the
development of an important plant trait, chemical screens can
uncover modiﬁers of this response. For example, the presence
of glutamate inﬂuences root system architecture by restrict-
ing primary root elongation and promoting the proliferation
of lateral roots (Walch-Liu et al., 2006). Modifying root sys-
tem architecture can beneﬁt plant growth in response to new
2http://www.plantcyc.org
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environments and abiotic stresses (Lynch, 1995; Comas et al.,
2013). Screening for compounds that antagonized glutamate per-
ception uncovered novel components of a glutamate signaling
pathway and facilitated the development of chemical tools that
promote root development in response to endogenous cues (Forde
et al., 2013). Targeting metabolic pathways by high-throughput
chemical screening should glean new insight into the mecha-
nisms through which metabolites inﬂuence plant growth and
development.
Directing metabolic output through genetic engineering has
been a goal of plant scientists for some time. The development
of Golden Rice, engineered to synthesize β-carotene in its seeds
(Ye et al., 2000; Paine et al., 2005), demonstrated the potential of
metabolic engineering to enhance nutritional value of staple crops
(Tang et al., 2009). Vitamin A deﬁciency is a major health con-
cern in many parts of the developing world, and can result in
permanent blindness and death (Underwood and Arthur, 1996).
Consuming β-carotene, the precursor toVitaminA, can help com-
batmalnutrition in some of the world’s poorest populations (Tang
et al., 2009). Unfortunately, efforts to implement this technology
in regions that stand to beneﬁt the most from it have been stymied
by governments and activists in opposition of geneticmodiﬁcation
(Enserink, 2008).
Despite the difﬁculties bringing Golden Rice to the ﬁeld,
it has demonstrated that metabolic engineering can promote
nutritional value in crops and raises questions about the ability
to use chemicals analogously to genetic engineering in direct-
ing the metabolic output of plant. If enzymes make good
drug targets then it should be possible to uncover chemicals
that can direct metabolic ﬂux by modulating biosynthetic path-
ways. Presumably, blocking metabolism at crucial time-points
during plant development can promote the accumulation of spe-
ciﬁc metabolites that could have economic or nutritional value.
Methods that enable quick assessment of metabolite abundance
would facilitate screens in search of compounds that promote
the accumulation of metabolites of interest. Though we are
not necessarily advocating for increased application of chem-
icals to food products, we believe that targeted manipulation
of plant metabolism through chemical biology does have the
potential to promote nutritional value in crops and to enhance
the accumulation of rare or expensive natural products in some
species.
Similarity between crop species is beneﬁcial to plant researchers
because treatments that are effective in one species are likely to
be useful in a related species. In principal, this should facilitate
translation from laboratory science to real-world applications.
Despite this, there seems to be a paucity of published exam-
ples in which leads from high-throughput screens in Arabidopsis
were then tested across agriculturally important species. Some
characteristics of the model plant Arabidopsis, including its small
size and rapid growth, make it an obvious choice as the sub-
ject of phenotype-based high-throughput chemical screening
(Robert et al., 2009). As sequenced genomes become readily avail-
able and as new tools are developed for other plant species,
compounds identiﬁed using Arabidopsis should be assayed in
other plants to assess the utility of these leads in commer-
cial applications. Focus on the development of compounds that
modify traits in important species might encourage collabo-
ration between the Ag-biotech sector and academic research
groups, a relationship that has stimulated innovation in the
pharmaceutical industry (Scudellari, 2011; Loregian and Palu,
2013).
LESSONS FROM BIG PHARMA
In many ways, the Ag-chem industry is facing a similar situa-
tion to the pharmaceutical industry, in which exorbitant costs of
drug development have become prohibitive. This has resulted in
a stagnating supply of innovative new products coming through
the research and development pipeline (Bennani, 2011; Pammolli
et al., 2011). The increasing market share being lost to generics
and some valuable patents expiring over the past few years have
put pressure on Big Pharma to restructure their lead develop-
ment strategy (Cuatrecasas, 2006; Loregian and Palu, 2013). Over
the past decade, an increasing number of large pharmaceutical
companies have established fruitful collaboration with academic
research laboratories, effectively “outsourcing” discovery-based
lead generation (Scudellari, 2011; Fishburn, 2013). In sup-
port of this, universities across the world have established
high-throughput screening facilities that enable drug discov-
ery (Loregian and Palu, 2013). In this model, discovery-based
research is handled by the academic institution; commercial-
ization and product development are generally managed by the
corporation.
This relationship has allowed the burden of high-risk projects
to be taken by the research institute, whose incentives and mea-
sures of success may differ from that of the corporate partner
(Fishburn, 2013; Loregian and Palu, 2013). An academic group
may put greater value in publications and training opportu-
nities (Loregian and Palu, 2013), or may be more interested
in pursuing high-risk projects that attempt to drug difﬁcult
targets, such as transcription factors and protein–protein inter-
actions (Loregian and Palu, 2013). In this sense, the needs
of society beneﬁt from close collaboration between academic
labs and Big Pharma. These collaborations can mean more
attention paid to rare or neglected diseases, greater propen-
sity to tackle historically difﬁcult targets, and the generation of
new molecular entities that can be developed into therapeutic
treatments.
A similar strategy would beneﬁt the Ag-biotech industry, in
which academic chemical biology labs couldmake use of the avail-
able high-content screening platforms to develop new herbicides
and agricultural chemicals. The prevalence of herbicide-resistant
weeds, coupled with the increased abiotic stresses crippling agri-
cultural output are putting pressure on the Ag-chem industry
to develop innovative methods of crop protection that sidestep
the need for genetic modiﬁcation. Modern genomic analysis
should enable researchers to quickly understand the mecha-
nism of resistance, and scientists now have the tools available to
develop tailored chemical treatments that target speciﬁc classes
of weeds and other pests. Taking a lead from Big Pharma,
the private sector and academic laboratories should collabo-
rate to establish translational research programs that promote
innovation and open new opportunities to sustain agricultural
productivity.
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APPENDIX
Table A1 | Plant growth regulators used in agriculture.
Growth regulator Mode of action Agronomic benefit Species
Hormone action
IBA Auxin analog Rooting of stem cuttings Many plants
2,4-D Auxin analog Prevent fruit drop Apple, pear, citrus
4-CPA Auxin analog Stimulate fruit setting Tomato
NAA Auxin analog Fruit thinning Apples, pear
GA Plant hormone Fruit size increase Grapes
GA Plant hormone Delay fruit ripening Apple, pear, citrus
GA Plant hormone Increase yield Sugarcane
GA Release enzymes Malting Barley
Ethephon Ethylene release Rubber production Hevea
Ethephon Ethylene release Promote abscission Cherry, walnut, olive
Ethephon Ethylene release Fruit ripening Apple, tomato
Ethephon Ethylene release Color, fruit acidity Grapes
Ethephon Ethylene release Promoting leaf senescence Tobacco
Benzyladenine (BA) Cytokinin analog Lateral bud formation White pine
Accel Cytokinin analog Increase lateral branching Carnations
Promalin Mixture GA4/7+BA Fruit diameter Apple
Promalin Mixture GA4/7+BA Increase lateral branching Apple trees
Growth retardants
Chloromequat GA synthesis inhibitor Stem growth Poinsettia
Ancymidol GA synthesis inhibitor Stem growth Easter lily
Mepiquat GA synthesis inhibitor Reduce excessive growth Cotton
Chlorﬂurenol GA synthesis inhibitor Reduce growth Turf grass
Diaminozide GA synthesis inhibitor Increase fruit set Grapes
Diaminozide GA synthesis inhibitor Color Cherry
Diaminozide GA synthesis inhibitor Flower bud formation Apple, pear
Paclobutrazol GA synthesis inhibitor Control tree size Fruit trees
Miscellaneous
Maleic hydrazide Unknown Inhibit sprouting Onion, potato
Glyphosine Glyphosate analog Increases sugar yield Sugarcane
Dimethipin Unknown Defoliant Cotton
Chemicals that promote a variety of agriculturally important growth traits have been developed for use in the ﬁeld.
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